Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis

Fig. 3

Pooled odds ratios for pathological complete response (pCR) of neoadjuvant chemotherapy plus immune checkpoint inhibitors versus neoadjuvant chemotherapy in three subgroups analysis. A The pCR analysis according to different programmed death ligand 1 expression status. B The pCR analysis according to different nodal status. C The pCR analysis according to different Eastern Cooperative Oncology Group performance-status score

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us